Mounjaro
Mounjaro (tirzepatide) is a medication used for managing type 2 diabetes and supporting weight loss. It is a dual agonist that activates both GLP-1 and GIP receptors, which helps regulate blood sugar levels and appetite. Here are some key details about Mounjaro:
| Detail | Information |
|---|---|
| Active Ingredient | Tirzepatide |
| Brand Name | Mounjaro |
| Drug Class | Dual GLP-1 and GIP receptor agonist |
| Indications | Type 2 diabetes management, weight loss |
| Administration | Subcutaneous injection (once weekly) |
| Dosage Forms | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg pre-filled pens |
| Common Side Effects | Nausea, vomiting, diarrhea, constipation, abdominal pain |
| Benefits | Lowers blood sugar levels, promotes weight loss, improves insulin sensitivity |
| Contraindications | Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2) |
Mounjaro has shown significant results in clinical trials, with participants losing up to 20% of their body weight over 72 weeks. It is a promising option for individuals looking to manage their weight and improve their overall health.